DECK

Deckers Outdoor Corp. 10-Q Summary

Business Context and Reporting Period

This is a Quarterly Report (Form 10-Q) for Deckers Outdoor Corp. for the period ended June 30, 2003. The company operates four reportable segments: Teva, Simple, and Ugg wholesale divisions, and a newly acquired catalog and internet retailing business. The filing includes unaudited condensed consolidated financial statements.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 8.8% for the quarter and 8.7% for the six-month period compared to the prior year. Teva wholesale sales drove this growth, increasing 8.5% (quarter) and 7.1% (six months).
• Profitability Surge: Net income for the quarter increased 212% to $2.0 million. For the six months, the company reported net income of $6.2 million, compared to a net loss of $6.2 million in the prior year. The prior year loss was significantly impacted by a $8.97 million non-cash goodwill impairment charge related to the adoption of SFAS 142.
• Expense Reduction: Selling, general, and administrative (SG&A) expenses decreased 20.2% for the quarter and 24.8% for the six months. This was primarily due to the elimination of Teva royalty and license costs following the November 2002 acquisition of Teva assets, and a $500,000 reversal of an accrual for anti-dumping duties following a favorable court ruling.
• Segment Performance:
  • Teva: Strong performance with operating income of $7.0 million (quarter) and $18.0 million (six months).
  • Simple: Declined significantly with operating losses of $316,000 (quarter) and $181,000 (six months) due to a 47.9% drop in sales.
  • Ugg: Improved to an operating income of $124,000 (quarter) from a loss, though still a slight loss for the six months.
  • Catalog/Internet: New segment contributing $372,000 (quarter) and $485,000 (six months) to operating income.
• Debt Reduction: The company repaid $6.7 million of long-term debt during the six-month period, including a $2 million early repayment of subordinated debt in June 2003.

Guidance, Outlook, and Risks

• Fiscal 2003 Guidance: Management anticipates full-year sales between $104 million and $108 million, with diluted EPS ranging from $0.57 to $0.59.
• Q3 2003 Outlook: Sales expected to range from $19 million to $20 million. A diluted loss per share of ($0.04) to ($0.05) is expected due to seasonality.
• Brand Forecasts: Teva sales projected at $70–$72 million; Simple at $9–$10 million; Ugg at $25–$26 million.
• Risks:
  • Seasonality: Teva sales peak in Q1/Q2, while Ugg sales peak in Q4. Q3 is historically the lowest volume quarter.
  • Weather Sensitivity: Cooler spring/summer weather could hurt Teva; warm fall/winter weather could hurt Ugg.
  • Consumer Preferences: Rapid shifts in trends could lead to obsolete inventory.
  • Liquidity: While working capital is strong ($24.4 million), the company relies on a revolving credit facility with $11.5 million available.
• Unusual Items: The $500,000 reversal of anti-dumping duties and the elimination of Teva royalties were significant one-time or structural benefits to the current period's results.

Investor Verification Checklist

• Verify the sustainability of the Teva brand's growth following the acquisition of its intellectual property and the elimination of royalty payments.
• Monitor the Simple brand's declining sales trend and the effectiveness of management's strategy to reverse the operating losses.
• Confirm the impact of the strong Euro on future margins, as a significant portion of sales is international.
• Review the company's ability to manage inventory levels, particularly for Ugg, given the seasonal nature of the business and the recent inventory buildup.
• Assess the company's debt service obligations, noting the recent reduction in subordinated debt and the terms of the revolving credit facility.